We are live on
!
Find out more
MU
Mirova US Portfolio holdings
AUM
$8.81B
1-Year Est. Return
21.38%
This Fund
S&P 500
This Quarter
Est. Return
-9.99%
1 Year Est. Return
+21.38%
3 Year Est. Return
+80.7%
5 Year Est. Return
+106.85%
10 Year Est. Return
–
AUM
$5.21B
AUM Growth
-$116M
(-2.2%)
Cap. Flow
+$459M
Cap. Flow
% of AUM
8.81%
Top 10 Holdings %
Top 10 Hldgs %
63.68%
Holding
28
New
1
Increased
23
Reduced
–
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$135M |
| 2 |
Adobe
ADBE
|
+$61M |
| 3 |
NextEra Energy
NEE
|
+$54.3M |
| 4 |
Mastercard
MA
|
+$32.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$29.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$110M |
| 2 |
Waste Management
WM
|
+$1.79M |
| 3 |
AVLR
Avalara, Inc.
AVLR
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.85% |
| 2 | Healthcare | 20.89% |
| 3 | Financials | 16.3% |
| 4 | Consumer Discretionary | 12.96% |
| 5 | Utilities | 6.23% |
Similar funds
MERSOM
CFB
MOACM
SWP
CB
WT
OAM
PEA
Mirova US's Q1 2022 Portfolio in Review
As of Q1 2022, Mirova US held 28 positions worth $5.21B, down 2.2% from $5.32B the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Mirova US deployed $459M of net new capital in Q1 2022, opening 1 new position and adding to 23 existing holdings. Its largest new stake was Verizon: 2,541,483 shares worth $129M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the most notable exit was Oracle, an estimated $110M sold.
- Mirova US's largest Q1 2022 buy was Verizon: 2,541,483 shares worth $129M.
- Mirova US added most to Adobe in Q1 2022, an estimated $61M increase.
- Mirova US fully exited Oracle in Q1 2022, selling an estimated $110M.
- Mirova US's ten largest holdings make up 64% of its $5.21B portfolio in Q1 2022.
- Mirova US opened 1 new position and closed 3 in Q1 2022.
- Mirova US's portfolio value fell 2.2% quarter-over-quarter to $5.21B.
Based on Mirova US's 13F filing for Q1 2022, filed 6 May 2022.